Ontology highlight
ABSTRACT: Objective
We examined the clinical and pathologic phenotypes of GRN mutation carriers with the pathogenic A9D (g.26C>A) missense mutation.Methods
Three patients with GRN A9D mutations were evaluated clinically and came to autopsy with subsequent neuropathologic examination.Results
The clinical diagnoses of patients with GRN A9D mutations were amyotrophic lateral sclerosis, atypical extrapyramidal disorder, and behavioral variant frontotemporal dementia. Immunohistochemistry for TAR DNA-binding protein 43 (TDP-43) revealed variability in morphology and distribution of pathology. One patient had notable involvement of motor neurons in the spinal cord as well as type B TDP-43, whereas 2 other patients had type A TDP-43.Conclusions
The clinical presentation of the GRN A9D missense mutation is not restricted to behavioral variant frontotemporal dementia and may include aphasia, extrapyramidal features, and, notably, amyotrophic lateral sclerosis.
SUBMITTER: Cannon A
PROVIDER: S-EPMC3719429 | biostudies-literature | 2013 May
REPOSITORIES: biostudies-literature
Cannon Ashley A Fujioka Shinsuke S Rutherford Nicola J NJ Ferman Tanis J TJ Broderick Daniel F DF Boylan Kevin B KB Graff-Radford Neill R NR Uitti Ryan J RJ Rademakers Rosa R Wszolek Zbigniew K ZK Dickson Dennis W DW
Neurology 20130417 19
<h4>Objective</h4>We examined the clinical and pathologic phenotypes of GRN mutation carriers with the pathogenic A9D (g.26C>A) missense mutation.<h4>Methods</h4>Three patients with GRN A9D mutations were evaluated clinically and came to autopsy with subsequent neuropathologic examination.<h4>Results</h4>The clinical diagnoses of patients with GRN A9D mutations were amyotrophic lateral sclerosis, atypical extrapyramidal disorder, and behavioral variant frontotemporal dementia. Immunohistochemist ...[more]